The GAVI Alliance has “announced a major new initiative aimed at engaging private sector leaders: the GAVI Matching Fund,” through which “the British Government’s Department for International Development (DFID) and the Bill & Melinda Gates Foundation will provide a 100 percent match of contributions to GAVI from corporations and foundations as well as their customers, members and employees,” Bill Roedy, former CEO of MTV Networks and a GAVI Alliance envoy, writes in a post on the Huffington Post’s “Impact” blog. “Together, DFID and the Gates Foundation have pledged $130 million to support this effort, which means there’s the potential to generate $260 million for global childhood immunization efforts,” he notes.
Private Sector Involvement
The Guardian profiles Brian Brink, chief medical officer at Anglo American, South Africa’s largest private-sector employer, and the company’s efforts to treat and prevent HIV among its employees. According to the newspaper, “HIV affects 12,000 of its employees, or 16 percent of its 70,000-strong permanent staff.” The Guardian continues, “For Anglo, a healthy workforce is a more loyal and productive one,” which is why it offers HIV testing and treatment free-of-charge to employees, runs HIV prevention programs, and promotes gender equality. “Not only is it a moral imperative to get on top of the AIDS problem, it’s also good for business, and the wider South African economy. The prevalence of AIDS and HIV [the virus that leads to AIDS] probably lops one percent off the country’s GDP,” Brink said (11/3).
“Food security concerns as the world’s population surpasses seven billion have prompted global companies to become more actively involved in ensuring future supplies, participants at an agricultural conference said on Monday,” Reuters reports. “The increased role has come at a time government involvement is hampered by the global financial crisis and led to fears a private sector-led expansion may focus on products with profit potential and neglect more effective alternatives,” according to the news agency. “‘We need to produce more food. The figures are debatable but we clearly need at least 50 percent more food in the next two or three decades,’ said Ian Crute, chief scientist at Britain’s Agriculture and Horticulture Development Board,” at the CropWorld 2011 conference (Hunt, 10/31).
In this Huffington Post opinion piece, Orin Levine, executive director of the International Vaccine Access Center at Johns Hopkins University, notes some of the parallels between the development of RTS,S, the experimental malaria vaccine currently being tested in Africa, and the polio vaccine, but he says “there are also some particularly disappointing ways in which the polio and malaria efforts could differ.”
Addressing Barriers To Successful Immunization Programs Important While Vaccine Development Progresses
Immunizations can be a cost-effective means of disease prevention, but “[t]o reach the fully realized stage of cost-effectiveness, … it is vital to acknowledge — and more importantly, address — the barriers that often prevent them from either being as cheap or as widely used as needed,” Forbes contributor Sarika Bansal writes in a Forbes opinion piece. She cites costs associated with vaccines, such as shipping and refrigeration; time and monetary commitments from potential vaccine recipients; a lack of medical professionals in rural areas; and the implementation of public awareness campaigns as barriers to successful immunization campaigns.
In this post on USAID’s “IMPACTblog,” Amanda Makulec, a monitoring and evaluation associate with John Snow Inc., discusses “the Alliance for Reproductive, Maternal, and Newborn Health, which was born over a year ago to support progress towards MDGs four and five in 10 priority countries, including Bangladesh, Ethiopia, India, Indonesia,…
Pharmaceutical firm Eli Lilly and Co. is expected to announce on Tuesday it “is pledging $30 million to help fight multidrug-resistant tuberculosis [MDR-TB] in developing countries, a disease that kills more than 150,000 people a year,” according to the Indianapolis Star. The funds, part of the company’s eight-year-old, $165 million Lilly MDR-TB Partnership, will help to “provide training for nurses, doctors and community volunteers; conduct studies on how to combat the disease; and provide access to medicines,” the newspaper notes. The campaign will focus on China, India, Russia and South Africa, “the four countries with the highest burden of MDR-TB, Lilly said,” the Indianapolis Star writes (10/25).
Positive results announced this week from a large clinical trial testing the efficacy of the RTS,S malaria vaccine are “encouraging,” but they are also “a reminder of how much work remains to be done,” an Economist editorial reports. The WHO abandoned its first efforts to eradicate the disease 14 years after setting out to do so in 1955, but “a new wave of enthusiasm,” beginning in 1998 with the establishment of the Roll Back Malaria partnership and culminating with Bill Gates’s call for malaria eradication four years ago, “has helped to lower the number of malaria deaths by 20 percent over the past decade,” the editorial states.
A new report from the Kaiser Family Foundation, titled “Innovative Financing Mechanisms for Global Health: Overview and Considerations for U.S. Government Participation,” “examines some of the most prominent new financing mechanisms for global health across a broad range of categories, with particular attention to the current level of U.S. government involvement,”…
USAID and Kimberly-Clark Corporation, a manufacturer of health and hygiene products, on Tuesday announced “they will work together to improve maternal and child health in the Andean region, starting in Colombia and Ecuador,” according to a USAID press release. Combining the U.S. government’s Global Health and Feed the Future initiatives…